MRT5005
- Generic Name
- MRT5005
- Drug Type
- Biotech
- Background
MRT5005 is a human cystic fibrosis transmembrane conductance regulator (hCFTR) messenger RNA (mRNA) complexed with branched polyethyleneimine (bPEI).
Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis
- First Posted Date
- 2017-12-15
- Last Posted Date
- 2020-11-16
- Lead Sponsor
- Translate Bio, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT03375047
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸National Jewish Health, Denver, Colorado, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath